Abstract
To the Editor: We thank Dr Firooz for pointing out the error in our review and for correctly stating the dosages of the multidrug therapy regimens for both paucibacillary and multibacillary leprosy. Multidrug therapy regimen for leprosyJournal of the American Academy of DermatologyVol. 55Issue 6PreviewTo the Editor: In the April 2006 issue of the journal, Lupi et al1 provided a comprehensive and instructive review of the bacterial tropical diseases. In the last paragraph of the section on leprosy, they stated that “Leprosy is treated with a multidrug therapy regimen with a daily dose of dapsone (100 mg/d) and clofazimine (50 mg/d), plus a monthly controlled dose of rifampicin (300 mg).” The correct multidrug therapy regimen recommended by World Health Organization is dapsone (100 mg/d) plus a monthly controlled dose of rifampicin (600 mg) for 6 months in paucibacillary leprosy and dapsone (100 mg/d) and clofazimine (50 mg/d), plus a monthly controlled dose of rifampicin (600 mg) and clofazimine (300) mg for 24 months in multibacillary leprosy. Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
